STAA
HOLD / NEUTRALNeutralComposite
40.60
Technical
24.40
Fundamental
51.40
Rank
—
Price
24.66
Hurst
0.54
As of
Aug 20, 2026
Daily
STAAR Surgical Company
HealthcareMedical Instruments & SuppliesSTAAR Surgical Company designs and manufactures implantable lens products used in refractive eye surgery to correct vision problems including myopia, hyperopia, astigmatism, and presbyopia. The company markets its lens systems and delivery equipment to ophthalmologists, surgical centers, and hospitals through direct sales teams in major markets and independent distributors globally. Founded in 1982 and based in California, the company serves the ophthalmic medical device sector.
Market cap
$1.1B
P/E (trailing)
265.50
P/E (forward)
20.75
PEG ratio
0.76
Dividend yield
—
Beta
1.22
52w range
15.59 – 35.87
Return on equity
+1.09%
Profit margin
+1.13%
Revenue growth
+111.00%
Earnings growth
—
Price history
1Y: 22.41 (-17.5%) · range 16.10–33.34
Cycle position
36/ 100 cycle scoreAPPROACHING ENTRY
ENTRYAPPROACHMID-BULLNEAR-TOPEXIT
entry readiness 54 · MODERATE · exit proximity 0
Conviction
34/ 100 · maturity 100%
VScore.4017
Buildup.2032
EMA entry setup.2554
Fundamentals.1551
Volume profile
POC
24.30
Price vs POC
-7.8%
Overhead supply
91%
Runway
+5.1%
Value area 22.28–28.89 · 91% of 120d volume overhead · heavy supply
Contributing sources
| Source | Score | Last seen |
|---|---|---|
| short-interest | 0.240 | Aug 31, 2026 |
| squeeze-risk | 0.188 | Aug 31, 2026 |
| earnings-surprise | 0.033 | Sep 10, 2026 |
Forward returns
| Horizon | Return | MFE | State |
|---|---|---|---|
| 20d | +1.21% | +7.91% | 10/20d |
| 40d | +1.21% | +7.91% | 10/40d |